3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Breast Neoplasms
9
Endometrial Neoplasms
4
Carcinoma, Renal Cell
4
Neuroendocrine Tumors
3
Tuberous Sclerosis
2
Recurrence
2
Neoplasm Metastasis
2
Kidney Neoplasms
2
Thyroid cancer, Hurthle cell
1
Thyroid Neoplasms
1
Thyroid Diseases
1
Solid Tumor
1
Seizures
1
Sarcoma
1
Primary Non-metastatic Breast Cancer
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Myelodysplastic Syndromes
1
Multiple Endocrine Neoplasia Type 1
1
Liposarcoma
1
Leukemia, Myeloid, Acute
1
Leiomyosarcoma
1
Gastro-enteropancreatic neuroendocrine tumor
1
Endometrial Hyperplasia
1
Clear-cell metastatic renal cell carcinoma
1
Breast Neoplasms, Male
1
Angiomyolipoma
1
Advanced Solid Tumors
1
Advanced Cancer
1
Interventions
Metformin
2
Megestrol Acetate
2
Pterocarpus marsupium
1
Levonorgestrel
1
Everolimus
1
Biopsy
1
3,5-dimethoxy-4'-hydroxystilbene
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Endometrial Hyperplasia
×
Everolimus
×
Clear all
NCT02397083
2026-02-13
LEVER
M.D. Anderson Cancer Center
Phase 2
Active not recruiting
102 enrolled